Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recruiting × Breast Neoplasms, Male × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Completed 9 Unknown 2 Active not recruiting 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 109 Carcinoma, Non-Small-Cell Lung 86 Prostatic Neoplasms 54 Colorectal Neoplasms 47 Nasopharyngeal Carcinoma 43 Neoplasms 40 Stomach Neoplasms 31 Multiple Myeloma 31 Lung Neoplasms 28 Neoplasm Metastasis 24 Leukemia, Myeloid, Acute 24 Carcinoma, Hepatocellular 24 Recurrence 22 Ovarian Neoplasms 22 Rectal Neoplasms 21 Squamous Cell Carcinoma of Head and Neck 20 Pancreatic Neoplasms 20 Uterine Cervical Neoplasms 19 Triple Negative Breast Neoplasms 19 Esophageal Neoplasms 19 Colonic Neoplasms 19 Brain Neoplasms 19 Small Cell Lung Carcinoma 17 Urinary Bladder Neoplasms 15 Myasthenia Gravis 14 Lymphoma, Large B-Cell, Diffuse 14 Lymphoma, Follicular 14 Esophageal Squamous Cell Carcinoma 13 Endometrial Neoplasms 13 Melanoma 12

Interventions

ribociclib 1 exemestane 1 Leuprolide 1 Letrozole 1 Goserelin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05827081 2026-03-02

Adjuvant WIDER

Novartis

Phase 3 Recruiting

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡